Peter A Csurhes
Overview
Explore the profile of Peter A Csurhes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
353
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ioannides Z, Csurhes P, Swayne A, Foubert P, Aftab B, Pender M
Mult Scler J Exp Transl Clin
. 2021 Jun;
7(2):20552173211019772.
PMID: 34158970
Background: Soluble triggering receptor expressed on myeloid cells-2 (sTREM-2) is a marker of macrophage and microglial activation and is increased in the cerebrospinal fluid (CSF) in multiple sclerosis (MS). Objective:...
2.
Ioannides Z, Csurhes P, Douglas N, Mackenroth G, Swayne A, Thompson K, et al.
Front Neurol
. 2021 Apr;
12:652811.
PMID: 33790852
Increasing evidence indicates a role for Epstein-Barr virus (EBV) in the pathogenesis of multiple sclerosis (MS). EBV-infected autoreactive B cells might accumulate in the central nervous system because of defective...
3.
Pender M, Csurhes P, Smith C, Douglas N, Neller M, Matthews K, et al.
JCI Insight
. 2020 Oct;
5(20).
PMID: 33055421
No abstract available.
4.
Pender M, Csurhes P, Smith C, Douglas N, Neller M, Matthews K, et al.
JCI Insight
. 2018 Nov;
3(22).
PMID: 30429369
Background: Increasing evidence indicates a role for EBV in the pathogenesis of multiple sclerosis (MS). EBV-infected autoreactive B cells might accumulate in the CNS because of defective cytotoxic CD8+ T...
5.
Pender M, Csurhes P, Burrows J, Burrows S
Clin Transl Immunology
. 2017 Jul;
6(6):e147.
PMID: 28748090
[This corrects the article DOI: 10.1038/cti.2016.87.].
6.
Pender M, Csurhes P, Burrows J, Burrows S
Clin Transl Immunology
. 2017 Feb;
6(1):e126.
PMID: 28197337
Mounting evidence indicates that infection with Epstein-Barr virus (EBV) has a major role in the pathogenesis of multiple sclerosis (MS). Defective elimination of EBV-infected B cells by CD8 T cells...
7.
Pender M, Csurhes P, Pfluger C, Burrows S
Mult Scler
. 2014 May;
20(14):1825-32.
PMID: 24842963
Background: Patients with multiple sclerosis (MS) have a deficiency of circulating CD8+ T cells, which might impair control of Epstein-Barr virus (EBV) and predispose to MS by allowing EBV-infected autoreactive...
8.
Pender M, Csurhes P, Smith C, Beagley L, Hooper K, Raj M, et al.
Mult Scler
. 2014 Feb;
20(11):1541-4.
PMID: 24493474
Defective control of Epstein-Barr virus (EBV) infection by cytotoxic CD8(+) T cells might predispose to multiple sclerosis (MS) by allowing EBV-infected autoreactive B cells to accumulate in the central nervous...
9.
Pender M, Csurhes P, Pfluger C, Burrows S
Blood
. 2012 Dec;
120(25):5085-7.
PMID: 23243157
No abstract available.
10.
Yan J, Liu J, Lin C, Csurhes P, Pender M, McCombe P, et al.
Int J Mol Sci
. 2012 Dec;
13(10):13667-79.
PMID: 23202972
Multiple sclerosis (MS) is an inflammatory demyelinating disease affecting the central nervous system. Although the exact pathogenesis of MS is unknown, it is generally considered to be an autoimmune disease,...